PDG59 THE IMPACT OF TEMPORARY AUTHORIZATION USE (ATU) DOSSIER IN FRANCE SINCE THE CREATION OF FFIP (PHARMACEUTICAL INNOVATION FINANCING FUND) IN 2017
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1073
https://www.valueinhealthjournal.com/article/S1098-3015(19)33451-5/fulltext
Title :
PDG59 THE IMPACT OF TEMPORARY AUTHORIZATION USE (ATU) DOSSIER IN FRANCE SINCE THE CREATION OF FFIP (PHARMACEUTICAL INNOVATION FINANCING FUND) IN 2017
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33451-5&doi=10.1016/j.jval.2019.09.1073
First page :
Section Title :
Open access? :
No
Section Order :
10941